Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 InterHealth Confirms Safety and Efficacy of Aller-7 - Nutraceuticals World
Research

InterHealth Confirms Safety and Efficacy of Aller-7

InterHealth Nutraceuticals has completed a multicenter clinical trial spanning three years and involving 545 patients in 14 clinical centers, confirming the safety and efficacy of Aller-7 in people with allergic rhinitis, or airborne allergies. The study, published in the International Journal of Clinical Pharmacology Research (XXIV (2/3):79-94, 2004), found that over a period of 12 weeks, 94% of patients in open label trials and 92% of patients in double-blind, placebo-controlled trials treated with Aller-7 reported an improvement in symptoms ranging from more than 40% to 100%. Complete relief from sneezing, running nose and nasal congestion in open label trials was seen in 28%, 37% and 45% of patients, respectively. No serious side effects were observed, thus demonstrating that Aller-7 is both well tolerated and efficacious in combating the symptoms of airborne allergies. Aller-7 is a patented blend of seven herbal extracts, including Phyllanthus emblica (fruit), Terminalia chebula (fruit), Terminalia bellerica (fruit), Albizia lebbeck (bark), Zingiber officinale (root), Piper longum (fruit) and Piper nigrum (fruit).

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters